Over 10 years experience of Traceability Solutions
By pharmatrax
Category: News
No Comments(HealthDay)—Recall of a cardiac resynchronization therapy pacemaker, which occurred in November 2015, was delayed unnecessarily, according to a report published online Dec. 20 in JAMA Internal…
By pharmatrax
Category: News
No CommentsEntrepreneurs and executives are using the technology to create data markets and to reduce the burden of bureaucracy. The hype around blockchain in healthcare has…
By pharmatrax
Category: News
No CommentsThe tablets are being recalled because of the presence or potential presence of N-nitrosodimethylamine (NDMA) levels above the acceptable daily intake levels established by the…
By pharmatrax
Category: News
No CommentsThe United States has seen the call back of major drugs in the nation as well as in the international markets where the US-based companies…
By pharmatrax
Category: News
No CommentsThree major Indian drugmakers received warning letters from the U.S. health care watchdog in the last two months, highlighting that the country’s copycat drug sector…
By pharmatrax
Category: News
No CommentsDrugmakers may be recalling the heartburn med Zantac around the world, but the FDA wants consumers to stop worrying. Higher-than-recommended levels of a possible carcinogen in the pills are…
By pharmatrax
Category: News
No CommentsAbove: Chemists have a return and refund policy when pharma companies recall their products; pharmaceutical firm GSK has recalled Zinetac tablets 150 mg and 300…
By pharmatrax
Category: Technoloy
No CommentsA package of new guidance documents from the FDA describes what and how the agency plans to regulate as software designed to aid clinical decision-making—such…
By pharmatrax
Category: News
No CommentsTorrent Pharmaceuticals Limited is the latest drug company to issue a recall of losartan potassium, a popular blood pressure drug that’s been under scrutiny for…
By pharmatrax
Category: News
No CommentsFederal health officials have learned that Sanofi’s heartburn medication Zantac includes an impurity that could cause cancer, the U.S. Food and Drug Administration said Friday. The probe comes…